Guideline / position statementindependent cross-checkabstract checked I-SRC-134 standard review
International kidney disease guideline 2024
KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease.
Overview
KDIGO CKD Work Group. Kidney Int 2024 · PMID 38490803 · DOI 10.1016/j.kint.2023.10.018
Recommends supervised diet changes and kidney-protective drugs for chronic kidney disease.
Does the study support the specific claim? No · Methodological quality: high
Plain-language summary
Study explained simply
- What did the researchers want to find out?
Guide CKD care
- How was the study done?
GRADE guideline
- How many people, animals or samples were studied?
not applicable
- What was actually found?
Protein about 0.8 g/kg/day; salt limits; SGLT2 inhibitors
- How large was the observed effect?
not applicable
- What do the results mean in everyday life?
Kidney disease care is long term and supervised
- What are the study's limitations?
Only parts read
- What does it say about Elawady's specific claim?
Contradicts quick cures
- Do the results apply to Germany and Europe?
High
Scientific in-depth review
1. Full reference
- Authors
- KDIGO CKD Work Group
- Journal
- Kidney Int
- Year
- 2024
- Identifier
- PMID 38490803 DOI 10.1016/j.kint.2023.10.018
- Verification
- verified – PubMed efetch 2026-10-26; Crossref works record checked; no abstract in PubMed; recommendation statements read from https://kdigo.org/wp-content/uploads/2024/03/KDIGO-2024-CKD-Guideline.pdf (fetched 2026-10-26)
- Retracted
- no
- Corrections
- none
- Extent checked
- abstract only
- Conflicts of interest and funding
See guideline disclosures (not reviewed here).
2. Research question
How should CKD be evaluated and managed (not on kidney replacement therapy)?
3. Study design and population
- Study design
- Guideline / position statement – International clinical practice guideline (GRADE)
- Population
Adults and children with CKD
- Country
International
- Period
2024
- Sample size
not applicable
- Inclusion and exclusion criteria
not applicable
4. Methods and endpoints
- Exposure / intervention
Diet, medication, risk management
- Comparator
not applicable
- Endpoints
Recommendations
- Statistical methods
GRADE
5. Actual results
- Results
Recommendation 3.3.1.1: suggest maintaining protein intake of 0.8 g/kg/day in adults with CKD G3-G5 (2C). Practice point: very low-protein diets (0.3-0.4 g/kg/day) with keto-analogues only under close supervision in selected adults at risk of kidney failure; not in metabolically unstable people; do not restrict protein in children. Recommendation 3.3.2.1: sodium <2 g/day (2C). Recommendation 3.7.1: SGLT2 inhibitor for T2D with CKD and eGFR >=20 (1A).
- Absolute risks
not applicable
- Authors' conclusion
CKD management combines risk-based monitoring, diet adapted to stage, blood pressure and glucose control, and kidney-protective drugs.
6. Strengths
- International, GRADE-based, current
7. Weaknesses
- Only selected recommendations read
8. Risk of bias
- Orienting tool
- none applicable
- Type of assessment
- simplified assessment (abstract only)
- Full formal assessment
- no
- Overall risk of bias
- not assessable
- Rationale
Guideline.
9. Assessment of the statistical interpretation
Not applicable.
10. Relevance to the specific claim
Current standard: CKD is managed long term with diet and drugs; dietary measures are supervised and gradual; nothing suggests reversal of kidney failure within months.
11. Independent contrary findings
None.
12. Transferability to Germany and Europe
Used internationally, including Europe and Egypt.
13. Overall methodological judgement
Reference guideline.
| Multidimensional assessment | |
|---|---|
| Authenticity of the source | verified |
| Methodological quality | high |
| Risk of bias | not assessable |
| Precision of results | not applicable |
| Directness | direct |
| Reproducibility | unknown |
| Consistency with the overall evidence | consistent |
| Regional transferability | high |
| Adequacy of the interpretation (by the archive) | not applicable |
14. Open questions
15. Linked fact checks
- He could stop kidney failure and dialysis in all of Egypt within two months and prevent seasonal influenza within three weeks. – Studies contradicting or limiting the claim